Abstract
Aim:
To develop homogeneous calcium mobilization assay for high-throughput screening (HTS) of mas-related gene (Mrg) receptor agonists.
Methods:
CHO-K1 cells stably expressing the full-length MrgD receptor and a calcium-sensitive dye were used to develop an HTS assay based on intracellular calcium influx. This method was applied to large-scale screening of a library containing 8000 synthetic compounds and natural product extracts. cAMP measurements were carried out to verify the bioactivities of the hits found by the calcium mobilization assay. Similar approaches were also employed in the identification of the MrgA1 receptor agonists following HTS of 16 000 samples.
Results:
EC50 values of the positive control compounds (β-alanine for MrgD receptor and dynorphin A for MrgA1 receptor) determined by the calcium mobilization assay were consistent with those reported in the literature, and the Z′ factors were 0.65 and 0.50 for MrgD and MrgA1 receptor assay, respectively. About 31 compounds for the MrgD receptor and 48 compounds for the MrgA1 receptor showing ≥20% of the maximal agonist activities found in the controls were initially identified as hits. Secondary screening confirmed that 2 compounds for each receptor possessed specific agonist activities. Intracellular cAMP level measurements indicated that the 2 confirmed hits displayed the functionality of the MrgD receptor agonists.
Conclusion:
A series of validation studies demonstrated that the homogeneous calcium mobilization assay developed was highly efficient, amenable to automation and a robust tool to screen potential MrgD and MrgA1 receptor agonists. Its application may be expanded to other G-protein coupled receptors that mobilize calcium influx upon activation.
Similar content being viewed by others
Article PDF
References
Hopkins AL, Groom CR . The druggable genome. Nat Rev Drug Discov 2002; 1: 727–30.
Wise A, Gearing K, Rees S . Target validation of G-protein coupled receptors. Drug Discov Today 2002; 7: 235–46.
Dong X, Han S, Zylka MJ, Simon MI, Anderson DJ . A diverse family of GPCRs expressed in specific subsets of nociceptive sensory neurons. Cell 2001; 106: 619–32.
Lembo PM, Grazzini E, Groblewski T, O'Donnell D, Roy MO, Zhang J, et al. Proenkephalin A gene products activate a new family of sensory neuron-specific GPCRs. Nat Neurosci 2002; 5: 201–9.
Zylka MJ, Dong X, Southwell AL, Anderson DJ . Atypical expansion in mice of the sensory neuron-specific Mrg G protein-coupled receptor family. Proc Natl Acad Sci USA 2003; 100: 10043–8.
Grazzini E, Puma C, Roy MO, Yu XH, O'Donnell D, Schmidt R, et al. Sensory neuron-specific receptor activation elicits central and peripheral nociceptive effects in rats. Proc Natl Acad Sci USA 2004; 101: 7175–80.
Hong Y, Dai P, Jiang J, Zeng X . Dual effects of intrathecal BAM22 on nociceptive responses in acute and persistent pain-potential function of a novel receptor. Br J Pharmacol 2004; 141: 423–30.
Chen H, Ikeda SR . Modulation of ion channels and synaptic transmission by a human sensory neuron-specific G-protein-coupled receptor, SNSR4/mrgX1, heterologously expressed in cultured rat neurons. J Neurosci 2004; 24: 5044–53.
Shinohara T, Harada M, Ogi K, Maruyama M, Fujii R, Tanaka H, et al. Identification of a G protein-coupled receptor specifically responsive to beta-alanine. J Biol Chem 2004; 279: 23559–64.
Han SK, Dong X, Hwang JI, Zylka MJ, Anderson DJ, Simon MI . Orphan G protein-coupled receptors MrgA1 and MrgC11 are distinctively activated by RF-amide-related peptides through the Galpha q/11 pathway. Proc Natl Acad Sci USA 2002; 99: 14740–5.
Johnston PA, Johnston PA . Cellular platforms for HTS: three case studies. Drug Discov Today 2002; 7: 353–63.
Hann M, Hudson B, Lewell X, Lifely R, Miller L, Ramsden N . Strategic pooling of compounds for high-throughput screening. J Chem Int Comput Sci 1999; 39: 897–902.
Zhang JH, Chung TD, Oldenburg KR . A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J Biomol Screen 1999; 4: 67–73.
Zhang Y, Kowal D, Kramer A, Dunlop J . Evaluation of FLIPR calcium 3 assay kit-a new no-wash fluorescence calcium indicator reagent. J Biomol Screen 2003; 8: 571–7.
Moore K, Rees S . Cell-based versus isolated target screening: how lucky do you feel? J Biomol Screen 2001; 6: 69–74.
Feinberg SD . Prescribing analgesics. How to improve function and avoid toxicity when treating chronic pain. Geriatrics 2000; 55: 44–53.
Author information
Authors and Affiliations
Corresponding author
Additional information
Project supported partly by grants from the Ministry of Science and Technology of China (No 2004CB518902) and the Shanghai Municipality Government (No 04XD14023).
Rights and permissions
About this article
Cite this article
Zhang, R., Yan, Pk., Zhou, Ch. et al. Development of a homogeneous calcium mobilization assay for high throughput screening of mas-related gene receptor agonists. Acta Pharmacol Sin 28, 125–131 (2007). https://doi.org/10.1111/j.1745-7254.2007.00451.x
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1111/j.1745-7254.2007.00451.x
Keywords
This article is cited by
-
Application of chemical biology in target identification and drug discovery
Archives of Pharmacal Research (2015)
-
New Components of the Renin-Angiotensin System: Alamandine and the Mas-Related G Protein-Coupled Receptor D
Current Hypertension Reports (2014)